The latest in life sciences in Central MA

The new 63,000-square-foot facility located at 200 Donald Lynch Blvd. houses research and service laboratories, offices, and facilities for customer demonstrations and training, according to a press release from the firm issued Thursday. Currently hosting 50 Sartorius employees, the facility has room to accommodate more than 120 scientists and researchers. The goal of the new facility is to increase collaboration with customers and other external partners.  

Worcester’s journey to becoming a tech and biotech hub is rooted in its historical significance as a manufacturing city. During the 19th and early 20th centuries, Worcester was a thriving center for textiles, machinery, and manufacturing. However, as industries changed, the city faced economic decline, losing many of the factories and jobs that had defined its prosperity. The shift prompted local leaders to explore new paths, gradually moving Worcester’s focus toward technology, research, and education.  

Two Central Massachusetts life sciences companies are expanding their presence in the state, committing to a total of 130 new jobs as part of a state tax incentive program designed to bolster the life sciences industry.  

Date: October 29, 2024

This one day conference on October 29, 2024 at the DCU Center in Worcester, MA is expected to draw 200+ industry professionals, including representatives from Contract Development and Manufacturing Organizations., Contract Research Organizations, Biomanufacturing, Bio-industrial manufacturing, Federal representatives, Developers, Life Sciences, Real Estate, Startup organizations, and Membership Organizations from the Commonwealth and New England that will exchange ideas, latest technologies, best practices, and drive forward the future of biomanufacturing in our state.  

Massachusetts’ growing leadership in advanced modalities, coupled with a friendly state policy landscape and potential federal government resources, provide an opportunity for the Commonwealth to substantially expand its biomanufacturing footprint.  

Massachusetts Biomedical Initiatives (MBI) is calling on the state to designate Central Massachusetts as a Biomanufacturing Hub and invest in the region to help it compete in this growing industry.